Unilever offer for GSK consumer arm is short by £5bn say analysts
Published
Unilever’s rejected £50bn offer for Glaxo Smith Kline’s (GSK) consumer business falls short according to market analysts. Marmite maker Unilever has had three unsolicited offers rebuffed by GSK including a bid made last month which comprised of £41.7bn in cash and £8.3bn in company shares. Analysts have questioned the financial reasoning behind Unilever’s bid with [...]
Full Article